While HIV advocates have for many years been asking for the removal of stavudine 40mg from the first line drugs after studies showed its ability to cause grave side-effects on number of patients, the government never took action.
A source at the Ministry of Health said they had ordered many stocks of the Stavudine 40mg, and the country was going to make major losses if it cancelled the contracts. Also, the patients were going to suffer as new combination had not been identified and modalities to shift them to the new regimen.
As they play innocently in the compounds of displace persons, the smiles of HIV positive children belie the harrowing and near death situation they are in.
International agencies have just issued an alert that a significant number of the 12,000 children on antiretroviral (ARVs) drugs are part of the displaced persons and are unable to access their medication.
Kenyans will now have to wait for a couple of months before the much anticipated AIDS vaccine trials in Kagemi takes off,
following disappointing results of a different HIV vaccine trial conducted by Merck and Company.
The Kenya AIDS Vaccine Initiative (KAVI) research team has already written to local regulatory authorities informing them of the delay. In the communication they also explain that while the Merck and their vaccine are designed on the same concept, they are fundamentally different in other aspects.
If you do not believe in God or Worship at least once week, you may need to rethink your behavior in light of findings of a recent survey that shows Kenyans who have no religion to be the hardest hit with HIV.
Final findings of Kenya AIDS Indicator Survey (KAIS) to be released in a couple of weeks from now are reporting that HIV prevalence among people without a religion stand at 7.7 per cent against the national average of 7.1 per cent. Last year, when the preliminary findings of the survey were made public, this statistics were not part of them.
Numerous microbicidal products,
designed to be inserted into the vagina and or rectum prior to sexual intercourse for the prevention of HIV and other sexually transmitted infections are still being developed. A few years ago women had been given
hope of protecting themselves from HIV infection by use of microbicides.
Numerous microbicidal products, designed to be inserted into the vagina and or rectum prior to sexual intercourse for the prevention of HIV and other sexually transmitted infections are still being developed.
A few years ago women had been given hope of protecting themselves from HIV infection by use of microbicides.